I am a board certified internist and medical oncologist who cares for women with gynecologic malignancies including ovarian, uterine, and cervical cancers as well as other less common tumors.
My goal is to provide the highest quality in medical care with both standard and investigational treatments, and I participate in a variety of clinical trials aimed at improving the outcome for women with gynecologic cancer. I am an investigator in a variety of studies, but my personal research interest is to evaluate new approaches for ovarian cancer patients who are in remission after treatment. The goal of these studies is to prolong the remission and ultimately to prevent relapse. My colleagues and I are currently studying new drugs and agents such as vaccines that would help the immune system prevent the cancer from returning. I also evaluate immune targeted agents for ovarian cancer patients whose disease has returned after initial surgery and chemotherapy. I am an investigator in all of the clinical trials on the Gynecologic Medical Oncology Service, which provide a wide range of options for patients with gynecologic cancer. In addition to patient care, I participate in several committees for the Gynecology Oncology Group.
I also serve as the Deputy Physician-in-Chief for Clinical Research at Memorial Sloan Kettering where we are working to ensure that patients with all types of tumors have access to a wide variety of high-quality clinical trials when they are appropriate. We are focusing on new treatments developed by our own scientists as well as enriching partnerships with external sponsors. We are particularly directing our efforts at developing and conducting clinical trials with novel agents and new approaches in the most efficient manner. By completing trials and disseminating information about successful interventions as quickly as possible, we will be able to have a positive impact on the greatest number of patients — both those treated here at Memorial Sloan Kettering as well patients at other institutions throughout the world.
- Clinical Expertise: Gynecologic Oncology
- Languages Spoken: English
- Education: MD, The University of Mississippi Medical Center
- Residencies: Vanderbilt University Medical Center
- Fellowships: Memorial Sloan Kettering Cancer Center
- Board Certifications: Internal Medicine; Medical Oncology
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Co-Investigated by Paul Sabbatini
- A Phase 1/2 Study of Motolimod (VTX-2337) and MEDI4736 in Women with Recurrent, Platinum-Resistant Ovarian Cancer for Whom Pegylated Liposomal Doxorubicin (PLD) Is Indicated
- A Phase I Study of HDM201 in Patients with Advanced Cancers and a Normal TP53 Gene
- A Phase Ib Study of OMP-54F28 with Paclitaxel and Carboplatin in Patients with Recurrent Platinum-Sensitive Ovarian Cancer
- A Phase III Study of Doxil Alone and with Yondelis (Trabectedin) in Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more